ConforMIS Reports Third Quarter 2017 Financial Results
Nov 01, 2017 20:05 pm UTC| Business
BILLERICA, Mass., Nov. 01, 2017 -- ConforMIS, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement...
The Habit Restaurants, Inc. Announces Third Quarter 2017 Financial Results
Nov 01, 2017 20:06 pm UTC| Business
IRVINE, Calif., Nov. 01, 2017 -- The Habit Restaurants, Inc. (NASDAQ:HABT) (“The Habit” or the “Company”), today announced financial results for its third quarter ended September 26, 2017. Highlights for the third...
TTM Technologies, Inc. Reports Fiscal Third Quarter 2017 Results
Nov 01, 2017 20:05 pm UTC| Business
COSTA MESA, Calif., Nov. 01, 2017 -- TTM Technologies, Inc. (NASDAQ:TTMI), a leading global printed circuit board (“PCB”) manufacturer, today reported results for the third quarter of fiscal 2017, which ended October...
ZAGG Reports 2017 Third Quarter and Nine Months Results; Company Raises 2017 Outlook
Nov 01, 2017 20:05 pm UTC| Business
SALT LAKE CITY, Nov. 01, 2017 -- ZAGG Inc (Nasdaq: ZAGG), a leading global mobile lifestyle company, today announced financial results for the third quarter and nine months ending September 30, 2017. Third Quarter...
Cidara Therapeutics to Report Third Quarter 2017 Financial Results and Provide Corporate Update
Nov 01, 2017 20:05 pm UTC| Business
SAN DIEGO, Nov. 01, 2017 -- Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today announced that it will report third quarter 2017 financial...
Nov 01, 2017 20:05 pm UTC| Business
Third Quarter 2017 Net Sales of $170.5 Million Third Quarter 2017 Net Loss From Continuing Operations of $34 Million; Non-GAAP Adjusted EBITDA From Continuing Operations of Positive $12 Million U.S. Upper Extremities...
Conatus Pharmaceuticals Reports Third Quarter 2017 Financial Results and Program Updates
Nov 01, 2017 20:05 pm UTC| Business
SAN DIEGO, Nov. 01, 2017 -- Conatus Pharmaceuticals Inc. (Nasdaq:CNAT), a biotechnology company focused on the development and commercialization of novel medicines to treat liver disease, today announced financial...
South Africa’s plan to move away from coal: 8 steps to make it succeed
Germany lowers voting age to 16 for the European elections
IceCube researchers detect a rare type of energetic neutrino sent from powerful astronomical objects